Tecan shares rose after the laboratory instruments company said late Wednesday that it met its sales target for 2024. Shares rose 7.8% in early-morning trading to 229.80 Swiss francs, but remain down ...

The biotech's efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of intellectual-property theft in China. DDN attracts a $300 million infusion ...

The Biden administration is planning to impose more restrictions on chip sales to China and Russia, according to a report.

The Federal Reserve dropped its December meeting minutes, and let’s just say the message wasn’t pretty. Inflation is creeping ...